Globus Medical Inc financial data

Symbol
GMED on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2560 General Armistead Avenue, Audubon, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316 % -52.6%
Quick Ratio 139 % -29.5%
Debt-to-equity 26.7 % +122%
Return On Equity 1.01 % -90.7%
Return On Assets 0.8 % -91.7%
Operating Margin 3.05 % -85.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 135M shares +34.8%
Entity Public Float 4.6B USD +6.98%
Weighted Average Number of Shares Outstanding, Basic 135M shares +34.7%
Weighted Average Number of Shares Outstanding, Diluted 137M shares +34.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.24B USD +104%
Research and Development Expense 177M USD +119%
Operating Income (Loss) 68.1M USD -71.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 66.6M USD -74.5%
Income Tax Expense (Benefit) 25.9M USD -54.7%
Net Income (Loss) Attributable to Parent 40.7M USD -80.1%
Earnings Per Share, Basic 0.21 USD/shares -89.7%
Earnings Per Share, Diluted 0.2 USD/shares -90%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 82.5M USD -73.1%
Accounts Receivable, after Allowance for Credit Loss, Current 612M USD +155%
Inventory, Net 770M USD +130%
Assets, Current 1.92B USD +59%
Deferred Income Tax Assets, Net 18.2M USD -70.6%
Property, Plant and Equipment, Net 572M USD +131%
Operating Lease, Right-of-Use Asset 53.9M USD
Intangible Assets, Net (Excluding Goodwill) 867M USD +1478%
Goodwill 1.45B USD +631%
Other Assets, Noncurrent 77.6M USD +64.3%
Assets 4.99B USD +126%
Accounts Payable, Current 67.2M USD +98.6%
Employee-related Liabilities, Current 115M USD +145%
Accrued Liabilities, Current 216M USD +141%
Liabilities, Current 794M USD +412%
Deferred Income Tax Liabilities, Net 27.3M USD +415%
Operating Lease, Liability, Noncurrent 87.7M USD
Other Liabilities, Noncurrent 25.2M USD +74.7%
Liabilities 1.02B USD +347%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11.9M USD +37.8%
Retained Earnings (Accumulated Deficit) 1.07B USD -20.2%
Stockholders' Equity Attributable to Parent 3.98B USD +100%
Liabilities and Equity 4.99B USD +126%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 52.4M USD -1.74%
Net Cash Provided by (Used in) Financing Activities -116M USD -4036%
Net Cash Provided by (Used in) Investing Activities -46.6M USD -524%
Common Stock, Shares Authorized 775M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -113M USD -268%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 410M USD +33.9%
Deferred Tax Assets, Valuation Allowance 191M USD +3376%
Deferred Tax Assets, Gross 399M USD +314%
Operating Lease, Liability 98.8M USD
Depreciation 126M USD +139%
Payments to Acquire Property, Plant, and Equipment 28.6M USD +78.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 47.9M USD -77.3%
Lessee, Operating Lease, Liability, to be Paid 137M USD
Property, Plant and Equipment, Gross 1.05B USD +71.8%
Operating Lease, Liability, Current 11.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 15.5M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +55.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.9M USD
Unrecognized Tax Benefits 33.8M USD +3324%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.8M USD
Operating Lease, Payments 4.76M USD +611%
Additional Paid in Capital 2.91B USD +343%
Amortization of Intangible Assets 101M USD +463%
Depreciation, Depletion and Amortization 55.3M USD +205%
Deferred Tax Assets, Net of Valuation Allowance 208M USD +129%
Share-based Payment Arrangement, Expense 51.5M USD +49.9%